Canaccord Genuity Group Inc (CF)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 13.49 |
|---|---|
| 52-week range | 10.65 – 15.55 |
| Return, 1 month / 3 months | −5.5% / −7.4% |
| Return, 1 year / 3 years | +22.0% / +205.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -16.7% |
| Average daily value traded | 2.73M CAD |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Canaccord Genuity Group is a financial services company based in Canada. It operates through two main arms: an investment banking and advisory business that helps companies raise capital and complete transactions, and a wealth management business that provides investment advice and portfolio services to individual and institutional clients. Its operations span North America, the United Kingdom and other international markets, serving corporate clients and private investors.
On this site Canaccord Genuity Group Inc appears as a stock on the Toronto Exchange (Canada), code CF, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Canaccord Genuity Group Inc (CF) trades on the Toronto Exchange in Canada. It last closed at CAD 13.49 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 226 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.0% and over the last three months it fell 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.9% | ||
| From 52-week high | -13.1% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.4% | ||
| 6-month return | 11.3% | ||
| 12-month return, skipping the last month | 29.1% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.7% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.73M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | −5.5% |
| 3 months | −7.4% |
| 6 months | +11.3% |
| 1 year | +22.0% |
| 3 years | +205.3% |
| 5 years | +121.5% |
Signals
| 50-day / 200-day average | 13.98 / 13.11 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | CAD 0.1000 |
| 19 Jun 2026 | CAD 0.1000 |
| 27 Feb 2026 | CAD 0.0850 |
| 28 Nov 2025 | CAD 0.0850 |
| 29 Aug 2025 | CAD 0.0850 |
| 20 Jun 2025 | CAD 0.0850 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.